Trade Setup Summary:CDTX🟢
Trade Type: Long
Ticker: CDTX
Timeframe: 30-Min Chart
Pattern: Breakout from an ascending wedge (bullish continuation)
📈 Entry Point:
Around $25.50
Confirmed breakout from the wedge pattern
🔒 Stop-Loss:
Below $24.25
Just under the wedge support and last consolidation zone
🎯 Take Profit Target:
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25.736 CHF
−152.60 M CHF
1.16 M CHF
7.67 M
About Cidara Therapeutics, Inc.
Sector
Industry
CEO
Jeffrey L. Stein
Website
Headquarters
San Diego
Founded
2012
FIGI
BBG01MNYL765
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Cidara (CDTX) Develops Next-Gen Immunotherapy TreatmentsCidara Therapeutics, Inc. (CDTX) is a biotechnology company focused on developing long-acting anti-infectives and immunotherapies. Its lead product, rezafungin, targets serious fungal infections, while its Cloudbreak® platform is designed to treat and prevent viral diseases. With growing global dema
$CDTX can rise in the next daysContextual immersion trading strategy idea.
Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases
The demand for shares of the company looks higher than the supply.
Due to the spread of C
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange CIDARA THERAPEUTIC stocks are traded under the ticker CDTX.
CDTX stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in CIDARA THERAPEUTIC price.
We've gathered analysts' opinions on CIDARA THERAPEUTIC future price: according to them, CDTX price has a max estimate of 41.26 CHF and a min estimate of 28.88 CHF. Watch CDTX chart and read a more detailed CIDARA THERAPEUTIC stock forecast: see what analysts think of CIDARA THERAPEUTIC and suggest that you do with its stocks.
CDTX stock is 0.00% volatile and has beta coefficient of 2.03. Track CIDARA THERAPEUTIC stock price on the chart and check out the list of the most volatile stocks — is CIDARA THERAPEUTIC there?
Today CIDARA THERAPEUTIC has the market capitalization of 255.09 M, it has decreased by −15.05% over the last week.
Yes, you can track CIDARA THERAPEUTIC financials in yearly and quarterly reports right on TradingView.
CIDARA THERAPEUTIC is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CDTX earnings for the last quarter are −1.47 CHF per share, whereas the estimation was −3.14 CHF resulting in a 53.15% surprise. The estimated earnings for the next quarter are −1.52 CHF per share. See more details about CIDARA THERAPEUTIC earnings.
CIDARA THERAPEUTIC revenue for the last quarter amounts to 0.00 CHF, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CDTX net income for the last quarter is −20.79 M CHF, while the quarter before that showed −47.51 M CHF of net income which accounts for 56.25% change. Track more CIDARA THERAPEUTIC financial stats to get the full picture.
No, CDTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 13, 2025, the company has 38 employees. See our rating of the largest employees — is CIDARA THERAPEUTIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CIDARA THERAPEUTIC EBITDA is −100.24 M CHF, and current EBITDA margin is −7.14 K%. See more stats in CIDARA THERAPEUTIC financial statements.
Like other stocks, CDTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CIDARA THERAPEUTIC stock right from TradingView charts — choose your broker and connect to your account.